Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
Open Access
- 20 December 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 391 (10123), 850-859
- https://doi.org/10.1016/s0140-6736(17)32849-0
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic AttackStroke, 2012
- Contemporary Outcome Measures in Acute Stroke ResearchStroke, 2012
- Use of Ordinal Outcomes in Vascular Prevention TrialsStroke, 2008
- Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled studyThe Lancet Neurology, 2008
- A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and FeasibilityPLOS ONE, 2008
- Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic strokePlatelets, 2006
- Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trialStatistics in Medicine, 2003
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokeThe Lancet, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionThe Lancet, 1991